Adult B-ALL Treated by CART Cell Bridging Allogeneic Hematopoietic Stem Cell Transplantation
- Status
- UNKNOWN
- Phase
- EARLY_PHASE1
Clinical Trials Related to Cyclophosphamide
Related studies linked through entity extraction aliases.
FaR-RMS: An Overarching Study for Children and Adults With Frontline and Relapsed RhabdoMyoSarcoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
FT538 in Subjects With Advanced Hematologic Malignancies
- Status
- TERMINATED
- Phase
- PHASE1
Comparison of BTD and BCD Based Regimens in the Treatment of AL Amyloidosis
- Status
- UNKNOWN
- Phase
- PHASE4
Axi-cel in CNS Lymphoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
TiTAN-1: Safety, Proliferation and Persistence of GEN-011 Autologous Cell Therapy
- Status
- TERMINATED
- Phase
- PHASE1
A Study of Polatuzumab Vedotin, Rituximab and Dose Attenuated CHP in Older Patients With DLBCL
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
A Study of the Safety, Efficacy, and Pharmacokinetics of Tiragolumab in Combination With Atezolizumab and Chemotherapy in Participants With Triple-Negative Breast Cancer
- Status
- COMPLETED
- Phase
- PHASE1
²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
Mesothelin-targeted CAR T-cell Therapy in Patients With Mesothelioma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study of Brentuximab Vedotin and CHP in Frontline Treatment of PTCL With Less Than 10% CD30 Expression
- Status
- COMPLETED
- Phase
- PHASE2
Haploidentical HCT for Severe Aplastic Anemia
- Status
- RECRUITING
- Phase
- PHASE2
FT516 in Combination With Monoclonal Antibodies in Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Study Comparing Haploidentical Hematopoietic Stem Cell Transplantations (HSCTs) From Young Non-first-degree and Older First-degree Donors in Hematological Malignancies
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
- Status
- RECRUITING
- Phase
- PHASE1
Testing a New Immune Cell Therapy, GD2-Targeted Modified T-cells (GD2CART), in Children, Adolescents, and Young Adults With Relapsed/Refractory Osteosarcoma and Neuroblastoma, The GD2-CAR PERSIST Trial
- Status
- SUSPENDED
- Phase
- PHASE1
Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Mutated or Viral Neoantigens in a Patient With Metastatic Cancer Plus the Administration of Pembrolizumab
- Status
- WITHDRAWN
- Phase
- PHASE2
Regorafenib in Combination With Metronomic Chemotherapies, and Low-dose Aspirin in Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
Testing the Use of Steroids and Tyrosine Kinase Inhibitors With Blinatumomab or Chemotherapy for Newly Diagnosed BCR-ABL-Positive Acute Lymphoblastic Leukemia in Adults
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
A Combination of Acalabrutinib With R-CHOP in Subjects With Previously Untreated Non-GCB DLBCL (ACE-LY-312)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3